In this issue:
Ziresovir in hospitalised infants with RSV
Long-term daily oxygen therapy for 24 or 15 hours in severe hypoxaemia
Nirsevimab immunisation against bronchiolitis in infants
Intranasal influenza vaccine ± inactivated influenza vaccine
Nirmatrelvir-ritonavir after COVID-19 hospitalisation
Blood biomarker clusters to identify molecular patterns in pulmonary fibrosis
Medication adherence to inhalation therapy: COPD exacerbation risk
Inspiratory training for diaphragm muscle weakness-related dyspnoea after COVID-19
Lung volumes impact on elexacaftor/tezacaftor/ivacaftor response in CF + advanced lung disease
Benralizumab for allergic asthma
Please login below to download this issue (PDF)